This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
An Open Label, Phase I Dose-finding Study of BI 754111 in Combination With BI 754091 in Patients With Advanced Solid Cancers Followed by Expansion Cohorts at the Selected Dose of the Combination in Patients With Non-small Cell Lung Cancer and Other Solid Tumors
Sponsor: Boehringer Ingelheim
This PHASE1 trial investigates Carcinoma, Non-Small-Cell Lung and Neoplasms and is currently completed. Boehringer Ingelheim leads this study, which shows 68 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
68 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE1
-
Sep 2025 — Feb 2026 [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
▶ Show 63 earlier versions
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE1
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE1
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting PHASE1
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE1
-
Feb 2023 — Mar 2023 [monthly]
Active Not Recruiting PHASE1
-
Jan 2023 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE1
-
Nov 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1
-
May 2022 — Jun 2022 [monthly]
Active Not Recruiting PHASE1
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting PHASE1
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE1
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting PHASE1
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE1
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1
-
Mar 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE1
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE1
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Recruiting PHASE1
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE1
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
May 2020 — Jun 2020 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE1
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE1
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE1
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE1
-
Dec 2017 — Mar 2018 [monthly]
Recruiting PHASE1
-
Nov 2017 — Dec 2017 [monthly]
Recruiting PHASE1
-
Aug 2017 — Nov 2017 [monthly]
Recruiting PHASE1
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .